DRMAW vs JKHY
Dermata Therapeutics Inc. Warrant (DRMAW) versus Jack Henry & Associates Inc (JKHY) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
DRMAW does not have a complete income-statement cache yet.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
DRMAW currently screens at market cap $0. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Not investment advice. Open the DRMAW and JKHY stock pages for the full models.
Not investment advice.